# Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation

> **NCT04488094** · PHASE2 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 7 (actual)

## Conditions studied

- Graft Rejection
- Heart Transplantation
- Liver Transplantation

## Interventions

- **DRUG:** [18F]FSPG

## Key facts

- **NCT ID:** NCT04488094
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-11-18
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-03-31
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04488094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04488094, "Diagnostic Validity of [18F]FSPG PET for the Assessment of Acute Rejection After Heart or Liver Transplantation". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04488094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*